This topic contains a solution. Click here to go to the answer

Author Question: If the information necessary to calculate corrected count increment (CCI) or post-transfusion ... (Read 59 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
If the information necessary to calculate corrected count increment (CCI) or post-transfusion platelet recovery (PPR) is not available,
 
  a rough estimate of _________ increment per one unit of platelet concentrate transfused in an average adult patient can be used.
 
  a. 500/L
  b. 1,000/L
  c. 2,000/L
  d. 5,000/L

Question 2

Platelet refractoriness can be indicated by an immediate post-transfusion corrected count increment (CCI) of less than
 
  a. 5,000 on at least one occasion
  b. 5,000 on at least two occasions
  c. 7,500 on at least one occasion
  d. 7,500 on at least two occasions



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Answer: c

Answer to Question 2

Answer: b




fbq8i

  • Member
  • Posts: 527
Reply 2 on: Jun 25, 2018
Gracias!


peter

  • Member
  • Posts: 330
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library